Pfizer Inc

Healthcare · Drug Manufacturers - General

27.70$ +0.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Pfizer Inc (PFE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 208,160 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PFE
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	14,667	15,336	18,302	20,574	33,510	39,153	46,356	116,775	123,684	117,565	114,837	115,268	111,148	212,949	195,014	188,002	185,798	172,101	169,274	167,460	171,615	171,797	159,422	167,488	154,229	181,477	197,206	226,501	213,396	208,160
Current Assets	6,468	6,820	9,931	11,191	17,187	18,450	24,781	29,741	39,694	41,896	46,949	46,849	43,076	61,670	60,468	57,728	61,415	56,244	57,702	43,804	38,949	41,141	49,926	32,803	35,067	59,693	51,259	43,333	50,358	42,898
Cash	1,150	877	1,552	2,358	1,099	1,036	1,878	1,520	1,808	2,247	1,827	3,406	2,122	1,978	1,735	3,182	10,081	2,183	3,343	3,641	2,595	1,342	1,139	1,305	1,784	1,944	416	2,853	1,043	1,142
Cash & Short-Term Investments	1,150	877	1,552	6,386	6,863	8,615	12,551	11,952	19,893	22,226	27,713	25,475	23,731	25,969	28,012	26,452	32,399	32,408	36,122	23,290	17,850	19,992	18,833	9,830	12,221	31,069	22,732	12,690	20,477	13,596
Receivables	2,252	2,220	2,914	5,368	5,489	5,067	6,184	9,027	10,020	9,613	9,906	10,460	9,782	15,840	15,079	22,438	10,675	9,357	8,669	10,838	11,266	11,271	11,399	12,068	11,194	15,745	14,529	11,177	14,777	15,841
Inventory	1,589	1,773	1,828	1,654	2,702	2,741	2,678	5,837	6,660	6,039	6,111	5,302	4,381	12,403	8,405	7,769	7,063	6,166	5,663	7,513	6,783	7,578	7,508	8,283	8,046	9,059	8,981	10,189	10,851	10,654
Property, Plant & Equipment	3,850	4,137	4,415	5,343	9,425	10,415	10,712	18,287	18,385	17,090	16,632	15,734	13,287	22,780	19,123	16,938	14,461	12,397	11,762	13,766	13,318	13,865	13,385	13,967	13,900	14,882	16,274	18,940	20,682	21,530
Goodwill	–	–	–	–	1,791	1,722	1,200	22,306	23,756	23,774	20,876	21,382	21,464	42,376	43,947	45,067	44,672	42,519	42,069	48,242	54,449	55,952	53,411	58,653	49,577	49,208	51,375	67,783	68,527	71,264
Intangible Assets	1,424	1,294	813	763	1,791	1,722	1,200	58,656	57,007	51,560	24,350	20,498	17,721	68,015	57,558	53,833	46,013	39,385	35,167	40,358	52,648	48,740	35,211	35,369	28,472	25,146	43,370	64,900	55,412	53,731
Total Liabilities	7,663	7,058	9,492	17,422	17,434	20,860	26,406	51,398	54,800	51,206	44,114	50,144	53,408	122,503	106,749	105,381	104,120	95,481	97,652	102,462	111,775	100,141	95,664	104,042	90,756	104,014	101,289	137,213	124,899	121,385
Current Liabilities	5,640	5,305	7,192	9,185	11,981	13,640	18,555	23,657	26,458	28,448	21,389	21,835	27,009	37,225	28,609	28,069	28,619	23,366	21,631	29,399	31,115	30,427	31,858	37,304	25,920	42,671	42,138	47,794	42,995	36,984
Short-Term Debt	2,235	2,251	2,729	5,299	4,289	6,263	8,669	8,818	11,266	11,589	2,434	5,825	9,320	5,469	5,623	4,016	6,424	6,027	5,141	10,160	10,688	9,940	8,836	16,190	2,703	2,241	2,945	10,877	7,302	3,484
Accounts Payable	913	660	971	1,889	1,719	1,411	1,620	2,587	2,672	2,073	2,019	2,270	1,751	4,370	4,026	3,836	2,921	3,234	3,440	3,620	4,536	4,656	4,674	4,220	4,309	5,578	6,809	6,710	5,633	5,240
Long-Term Debt	–	–	–	–	1,123	2,609	3,140	5,755	7,279	6,347	5,546	7,314	7,963	43,193	38,410	34,931	31,036	30,462	31,541	28,818	31,398	33,538	32,909	35,955	37,133	36,195	32,884	60,499	56,703	60,807
Shareholders' Equity	6,954	7,933	8,810	8,887	16,076	18,293	19,950	65,377	68,278	65,627	71,358	65,010	57,556	90,014	87,813	82,190	81,260	76,307	71,622	64,998	59,840	71,656	63,758	63,446	63,473	77,463	95,917	89,288	88,203	86,476
Retained Earnings	8,017	9,349	11,439	13,396	19,599	24,430	30,243	29,382	35,492	37,608	49,669	49,660	49,142	40,426	42,716	46,210	54,240	69,732	72,176	71,993	71,774	85,291	89,554	97,670	96,770	103,394	125,656	118,353	116,725	114,610
Shares Outstanding	3,858	3,952	3,939	6,317	6,368	6,361	6,241	7,286	7,614	7,411	7,274	6,939	6,750	7,045	8,074	7,870	7,508	6,895	1,285	1,251	1,232	1,212	5,977	5,675	5,632	5,708	5,733	5,709	5,700	5,686

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings